Mucosal Adjuvanticity of Fibronectin-Binding Peptide (FBP) Fused with Echinococcus multilocularis Tetraspanin 3: Systemic and Local Antibody Responses

PLoS Neglected Tropical Diseases

Volumn 6, Issue 9, 2012, Pages

  Dang, Zhisheng ^a,b   Feng, Jinchao ^a   Yagi, Kinpei ^c   Sugimoto, Chihiro ^d   Li, Wei ^e   Oku, Yuzaburo ^b  

^a MINZU UNIVERSITY OF CHINA   (China)

^b TOTTORI UNIVERSITY   (Japan)

^c HOKKAIDO INSTITUTE OF PUBLIC HEALTH   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e Qinghai Acad of Anim and Vet Med   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CPG OLIGODEOXYNUCLEOTIDE; FIBRONECTIN BINDING PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; TETRASPANIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ECHINOCOCCOSIS; ECHINOCOCCUS MULTILOCULARIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; MALE; MOUSE; MUCOSAL IMMUNITY; MYCOBACTERIUM AVIUM; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SOLUBILITY;

ADHESINS, BACTERIAL; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, HELMINTH; ANTIBODY FORMATION; ECHINOCOCCUS MULTILOCULARIS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; MYCOBACTERIUM AVIUM; RECOMBINANT FUSION PROTEINS; TETRASPANINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 84866918914     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001842     Document Type: Article

References (59)

1. Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM, (1992) Mucosal immunity: implications for vaccine development. Immunobiology 184 (2-3): 157-179.
2. McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, et al. (1992) The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10 (2) (): 75-88.
3. Holmgren J, Lycke N, Czerkinsky C, (1993) Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11 (12) (): 1179-1184.
4. Roberts M, Bacon A, Rappuoli R, Pizza M, Cropley I, et al. (1995) A mutant pertussis toxin molecule that lacks ADP-ribosyl transferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins. Infect Immun 63 (6) (): 2100-2108.
5. Borges O, Lebre F, Bento D, Borchard G, Junginger H, (2010) Mucosal vaccines: recent progress in understanding the natural barrier. Pharm Res 27 (2) (): 211-23.
6. Harandi AM, Sanchez J, Eriksson K, Holmgren J, (2003) Recent developments in mucosal immunomodulatory adjuvants. Curr Opin Investig Drugs 4 (2) (): 156-161.
7. Hopkins SA, Kraehenbuhl JP, Schodel F, Potts A, Peterson D, et al. (1995) A recombinant Salmonella typhimurinum vaccine induces local immunity by four different routes of administration. Infect Immun 63 (9) (): 3279-3286.
8. Krieg AM, Davis HL (2006) CpG ODN as a Th1 immune enhancer for prophylactic and therapeutic vaccines. Vaccine Adjuvants: Immunological and Clinical Principles (Hackett C. and Harn, DA, Jr., eds.). Totowa: Humana Press Inc. pp.87-110.
9. Giddings OK, Eickhoff CS, Sullivan NL, Hoft DF, (2010) Intranasal vaccinations with the trans-sialidase antigen plus CpG adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges. Infect Immun 78 (3) (): 1333-1338.
10. Aldridge JR, Johnson EC, Kuhn RE, (2010) CpG stimulates protective immunity in BALB/cJ mice infected with larval Taenia crassiceps. J Parasitol 96 (5) (): 920-928.
11. Kringel H, Dubey JP, Beshah E, Hecker R, Urban JF Jr, (2004) CpG-oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii. Vet Parasitol 123 (1-2) (): 55-66.
12. Verthelyi D, (2006) Adjuvant properties of CpG oligonucleotides in primates. Methods Mol Med 127: 139-158.
13. Dang ZS, Yagi K, Oku Y, Kouguchi K, Kajino K, et al. (2012) A pilot study of the intranasal recombinant tetraspanin vaccine in BALB/c mice against Echinococcus multilocularis infection. PLoS Negl Trop Dis 6 (3) (): e1570.
14. Schulze K, Medina E, Chhatwal GS, Guzmán CA, (2003) Stimulation of long-lasting protection against Streptococcus pyogenes after intranasal vaccination with non adjuvanted fibronectin-binding domain of the SfbI protein. Vaccine 21 (17-18) (): 1958-1964.
15. Guzman CA, Talay SR, Molinari G, Medina E, Chhatwal GS, (1999) Protective immune response against Streptococcus pyogene in mice after intranasal vaccination with the fibronectin-binding protein SfbI,. J Infect Dis 179 (4) (): 901-906.
16. Medina E, Talay SR, Chhatwal GS, Guzmán CA, (1998) Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route. Eur J Immunol 28 (3) (): 1069-1077.
17. Schulze K, Guzmán CA, (2003) Identification of the domains of the fibronectin-binding protein I of Streptococcus pyogenes responsible for adjuvanticity. FEMS Immunol Med Microbiol 37 (2-3) (): 173-177.
18. Talay SR, Valentin-Weigand P, Jerlstrom PG, Timmis KN, Chhatwal GS, (1992) Fibronectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells. Infect Immun 60 (9): 3837-3844.
19. Secott TE, Lin TL, Wu CC, (2002) Fibronectin attachment protein is necessary for efficient attachment and invasion of epithelial cells by Mycobacterium avium subsp. Paratuberculosis. Infec Immun 70 (5) (): 2670-2675.
20. Secott TE, Lin TL, Wu CC, (2004) Mycobacterium avium subsp. Paratuberculosis fibronectin attachment protein facilitates M-cell targeting and invasion through a fibronectin bridge with host integrins. Infec Immun 72 (7) (): 3724-3732.
21. Schorey JS, Holsti MA, Ratliff TL, Allen PM, Brown EJ, et al. (1996) Characterization of the fibronectin-attachment protein of Mycobacterium avium reveals a fibronectin-binding motif conserved among mycobacteria. Mol Microbiol 21 (2) (): 321-329.
22. Zhao W, Schorey JS, Groger R, Allen PM, Brown EJ, et al. (1999) Characterization of the fibronectin-binding motif for a unique mycobacterial fibronectin attachment protein, FAP. J Biol Chem 274 (8) (): 4521-4526.
23. Dang Z, Yagi K, Oku Y, Kouguchi H, Kajino K, et al. (2009) Evaluation of Echinococcus multilocularis tetraspanins as vaccine candidates against primary alveolar echinococcosis. Vaccine 27 (52) (): 7339-7345.
24. Kelley LA, Sternberg MJ, (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4 (3) (): 363-337.
25. Krieg AM, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (6522) (): 546-549.
26. Sparwasser T, Koch ES, Vabulas RM, Heeg K, Lipford GB, et al. (1998) Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 28 (6) (): 2045-2054.
27. Roman M, Martin-Orozco E, Goodman JS, Nguyen MD, Sato Y, et al. (1997) Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3 (8) (): 849-854.
28. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV, (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186 (10) (): 1623-1631.
29. McCluskie MJ, Davis HL, (1998) CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J Immunol 161 (9) (): 4463-4466.
30. Horner AA, Ronaghy A, Cheng PM, Nguyen MD, Cho HJ, et al. (1998) Immunostimulatory DNA is a potent mucosal adjuvant. Cell Immunol 190 (1) (): 77-82.
31. Moldoveanu Z, Love-Homan L, Huang WQ, Krieg AM, (1998) CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16 (11-12) (): 1216-1224.
32. Pater C, Müller V, Harraga S, Liance M, Godot V, et al. (1998) Intestinal and systemic humoral immunological events in the susceptible BALB/c mouse strain after oral administration of Echinococcus multilocularis eggs. Parasite Immunol 20 (12) (): 623-629.
33. Schorey JS, Li Q, McCourt DW, Bong-Mastek M, Clark-Curtiss JE, et al. (1995) A Mycobacterium leprae gene encoding a fibronectin binding protein is used for efficient invasion of epithelial cells and Schwann cells. Infect Immun 63 (7) (): 2652-2657.
34. Lee JS, Shin SJ, Collins MT, Jung ID, Jeong YI, et al. (2009) Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein activates dendritic cells and induces a Th1 polarization. Infect Immun 77 (7) (): 2979-2988.
35. Xue Y, O'Mara ML, Surawski PP, Trau M, Mark AE, (2011) Effect of poly (ethylene glycol) (PEG) spacers on the conformational properties of small peptides: a molecular dynamics study. Langmuir 27 (1) (): 296-303.
36. Zhang W, Ross AG, McManus DP, (2008) Mechanisms of immunity in hydatid disease: implications for vaccine development. J Immunol 181 (10) (): 6679-6685.
37. Radwanska M, Magez S, Michel A, Stijlemans B, Geuskens M, et al. (2000) Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei,. Infec Immun 68 (2) (): 848-860.
38. Snapper CM, Mond JJ, (1993) Towards a comprehensive view of immunoglobulin class switching. Immunol Today 14 (1) (): 15-17.
39. Vuitton DA, Gottstein B, (2010) Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay. J Biomed Biotechnol 2010: 923193.
40. Vuitton DA, (2003) The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop 85 (2) (): 119-132.
41. Gottstein B, Haag K, Walker M, Matsumoto J, Mejri N, et al. (2006) Molecular survival strategies of Echinococcus multilocularis in the murine host. Parasitol Int 55 (Suppl) (): S45-S49.
42. Gottstein B, Mesarina B, Tanner I, Ammann RW, Wilson JF, et al. (1991) Specific cellular and humoral immune responses in patients with different long-term courses of alveolar echinococcosis (infection with Echinococcus multilocularis). Am J Trop Med Hyg 45 (6) (): 734-742.
43. Gottstein B, (1992) Echinococcus multilocularis infection: immunology and immunodiagnosis. Adv Parasitol 31: 321-380.
44. Gottstein B, Wunderlin E, Tanner I, (1994) Echinococcus multilocularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57BL/6J) or resistant (C57BL/10) to secondary alveolar echinococcosis. Clin Exp Immunol 96: 245-252.
45. Vuitton DA, Zhang S, Yang Y, Godot V, Beurton I, et al. (2006) Survival strategy of Echinococcus multilocularis in the human host. Parasitol Int 55 (Suppl) (): S51-55.
46. Mourglia-Ettlin G, Marqués JM, Chabalgoity JA, Dematteis S, (2011) Early peritoneal immune response during Echinococcus granulosus establishment displays abiphasic behavior. PLoS Negl Trop Dis 5 (8) (): e1293.
47. Nono JK, Pletinckx K, Lutz MB, Brehm K, (2012) Excretory/secretory-products of Echinococcus multilocularis larvae induce apoptosis and tolerogenic properties in dendritic cells in vitro. PLoS Negl Trop Dis 6 (2) (): e1516.
48. Rigano R, Buttari B, Profumo E, Ortona E, Delunardo F, et al. (2007) Echinococcus granulosus antigen B impairs human dendritic cell differentiation and polarizes immature dendritic cell maturation towards a Th2 cell response. Infect Immun 75 (4) (): 1667-1678.
49. Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, et al. (2006) Tetraspanins on the surface of Schistosoma mansoniare protective antigens against schistosomiasis. Nat Med 12 (7) (): 835-840.
50. Cai P, Bu L, Wang J, Wang Z, Zhong X, et al. (2008) Molecular characterization of Schistosoma japonicum tegument protein tetraspanin-2: Sequence variation and possible implications for immune evasion. Biochem Biophy Res Commun 372 (1) (): 197-202.
51. Woof JM, Kerr MA, (2006) The function of immunoglobulin A in immunity. J Pathol 208 (2) (): 270-282.
52. Kilian M, Mestecky J, Russell MW, (1988) Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev 52 (2) (): 296-303.
53. Underdown BJ, Schiff JM, (1986) Immunoglobulin A strategic defense initiative at the mucosal surface. Annu Rev Immunol 4: 389-417.
54. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ, (1989) IgA-induced eosinophil degranulation. J Immunol 142 (7) (): 2393-2400.
55. Eckmann L, (2003) Mucosal defences against Giardia. Parasite Immunol 25 (5) (): 259-270.
56. Inaba T, Sato H, Kamiya H, (2003) Monoclonal IgA antibody-mediated expulsion of Trichinella from the intestine of mice. Parasitology 126 (Pt 6): 591-598.
57. Sardinha LR, Mosca T, Elias RM, do Nascimento RS, Gonçalves LA, et al. (2010) The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice. PLoS Negl Trop Dis 4 (1) (): e578.
58. Gottstein B, Felleisen R, (1995) Protective immune mechanisms against the metacestode of Echinococcus multilocularis. Parasitol Today 11: 320-326.
59. Harandi AM, Sanchez J, Eriksson K, Holmgren J, (2003) Recent developments in mucosal immunomodulatory adjuvants. Curr Opin Investig Drugs 4 (2) (): 156-161.